February 24, 2012 – The Confluence of Diagnostics & Therapeutics

The Confluence of Diagnostics and TherapeuticsLife Sciences

February 24, 2012
Location:
Indianapolis- Barnes & Thornburg LLP
11 South Meridian Street, Indianapolis, IN

Register
 
Overview
As the human genome has been mapped and understanding of genetic markers increases, opportunities to tailor treatment for specific patients and groups of patients should grow exponentially.  Turning this vision into reality will require coordinated efforts in both the diagnostic and pharmaceutical arenas However, the question can be asked as to which is more valuable – the test that identifies a patient’s condition or the treatment that alleviates or eliminates the condition.  This conference looks into how life sciences firms are partnering, merging, acquiring and/or competing in response and will delve into the discussion of value in the healthcare system and how it could/should be divided.

Life Sciences Niche Growing in Indianapolis?

According to the Indianapolis Region Guide 2010 put out by the IBJ, there’s more to Indiana Life Sciences than Eli Lilly, Dow AgroSciences, Cook Group, and Roche. In fact, Indianapolis has been attracting less known companies who are taking advantage of the great research universities, workforce, business climate, and commitment to life sciences growth.

AIT Laboratories, headquartered in Indianapolis, has more than 365 employees nationwide and hired roughly 180 employees in 2009. AIT increased their revenues by more than 75% and nearly doubled its national sales staff to 50 while also entering into 15 new markets.

Beckman Coulter is creating a center for excellence in Indianapolis. They’ve been in Indianapolis since 2006 and have about 450 people on site. In 2010 they will be adding roughly another 100 and increasing their footprint to 228K sq ft from 100K sq ft.

Reblog this post [with Zemanta]

November 13, 2009 – Indiana Life Sciences Collaboration series

The second offering of the Indiana Life Sciences Collaboration series for 2009/2010 is just a month away – Friday, November 13th at Cook Medical’s world headquarters in Bloomington. The topic of this conference is Comparative Effectiveness: the Dollars and Sense.

We thank our lead sponsors: Cook Medical, Taft Stettinius & Hollister LLP, AIT Laboratories and the IU Johnson Center for Entrepreneurship & Innovation  for developing this great program.  This topic touches everyone in the life sciences value chain in a time when healthcare reform promises to bring more emphasis on consumer choice and empowerment. Recognition of the importance of this topic is found in the stimulus package that was enacted earlier this year which allocated $1.1 billion for Comparative Effectiveness research.

Keynote presentations:

  • Scott Gottlieb, M.D., Resident Fellow, American Enterprise Institute for Public Policy Research
  • Paul Keckley, Executive Director, Deloitte Center for Health Solutions
  • And other experts from the following key organizations: Cook Group, IU School of Medicine, Clarian Health, NoMoreClipboard, OrthoPediatrics, Eli Lilly and Company, Indiana Health Information Exchange, SIHO Insurance Services and more!

To view the complete program, directions,  and to register please visit the Center for the Business of Life Sciences website.

This series works because of the great support and efforts of all our sponsors. See a full listing of the many companies and organizations who help us bring these conferences to you at- http://kelley.iu.edu/CBLS/sponsors/conference/page16541.html

Reblog this post [with Zemanta]